What is Adlon Therapeutics?
Adlon Therapeutics L.P. is a biopharmaceutical company dedicated to developing and providing treatment options for ADHD and related disorders. Our initial focus is on adults and adolescents who suffer from symptoms of Attention Deficit/Hyperactivity Disorder (ADHD). Adlon is a subsidiary of Purdue Pharma L.P.
How do I contact Adlon's medical team?
Our medical team is available and if you have questions related to our products please contact us; 1-888-827-0618; Ask Adlon Medical. Other contact information can be found here.
What is the intra-cellular therapies Patient Assistance Program?
The Intra-Cellular Therapies Patient Assistance Program is available to eligible patients who have been prescribed CAPLYTA ® (lumateperone) 42 mg and do not have health insurance. All applications are reviewed on a case-by-case basis in accordance with program eligibility criteria.
Is Adlon still in business?
Our business remains open. Our products are available, and we have not identified any supply chain risks at this time. Please continue to contact us through your normal channels. Our medical team is available and if you have questions related to our products please contact us; 1-888-827-0618; Ask Adlon Medical.
Cost Savings
At Purdue, we realize that the cost of medications is too high for many Americans. An important aspect of our commitment to effective and compassionate care is offering a savings program which may help reduce patients’ out-of-pocket costs that may otherwise interfere with the treatment prescribed by their healthcare provider.
Patient Savings Program for Purdue Prescription Medications
Patient Savings Program for OxyContin® (oxycodone HCI) extended‐release tablets CI I: If you have a valid prescription for OxyContin, please call 1‑855‑227‑0303 to speak to a call center representative about signing up for the savings program. Patients must meet eligibility requirements. Other restrictions may apply.
How to contact TrialCard Help Desk?
For questions regarding claim transmission, please call the TrialCard Help Desk at 1-866-420-7719 1-866-420-7719. By submitting this card for reimbursement, you certify that: You have dispensed the covered drug to an eligible patient in accordance with the terms of the card and accompanying prescription.
How to contact Adhansia XR?
If you have any questions regarding your eligibility or benefits, or if you wish to discontinue your participation, call the Adhansia XR Patient Savings Program at 1-866-420-7719 1-866-420-7719 (available 24 hours/day except major holidays). When you use this card, you are certifying that you understand the program rules, regulations, ...
How much does Adhansia XR cost?
Eligible patients may PAY AS LITTLE AS $15* for their prescription with the Adhansia XR Savings Card (up to 13 uses per card, per year).
What are the side effects of Adhansia XR?
The most common (≥5% and twice the rate of placebo) adverse reactions occurring with Adhansia XR in adults are insomnia, dry mouth, nausea, and decreased appetite.
Is Adhansia XR contraindicated?
Adhansia XR is also contraindicated in patients receiving concomitant treatment with monoamine oxidase inhibitors (MAOIs), and also within 14 days following discontinuation of treatment with a MAOI, because of the risk of hypertensive crisis.
Can Adlon Therapeutics revoke an offer?
Adlon Therapeutics L.P. reserves the right to rescind, revoke, or amend this offer without notice at any time.
Can Adhansia XR be used as a stimulant?
CNS stimulants, including Adhansia XR, other methylphenidate-containing products, and amphetamines, have a high potential for abuse and dependence. Assess the risk of abuse prior to prescribing, and monitor for signs of abuse and dependence while on therapy.
What are the side effects of Adhansia XR?
The most common (≥5% and twice the rate of placebo) adverse reactions occurring with Adhansia XR in adults are insomnia, dry mouth, nausea, and decreased appetite.
Can you improve symptoms after discontinuation of a stimulant?
Signs and symptoms generally improve after reduction in dose or discontinuation of drug. Careful observation for digital changes is necessary during treatment with ADHD stimulants. Further clinical evaluation (e.g., rheumatology referral) may be appropriate for certain patients.
Is Adhansia XR contraindicated?
Adhansia XR is also contraindicated in patients receiving concomitant treatment with monoamine oxidase inhibitors (MAOIs), and also within 14 days following discontinuation of treatment with a MAOI, because of the risk of hypertensive crisis.
Does Adhansia XR cause vasculopathy?
CNS stimulants, including Adhansia XR, used to treat ADHD are associated with peripheral vasculopathy, including Raynaud's phenomenon. Signs and symptoms are usually intermittent and mild; however, very rare sequelae include digital ulceration and/or soft tissue breakdown. Effects of peripheral vasculopathy, including Raynaud's phenomenon, were observed in post-marketing reports at different times and at therapeutic doses in all age groups throughout the course of treatment. Signs and symptoms generally improve after reduction in dose or discontinuation of drug. Careful observation for digital changes is necessary during treatment with ADHD stimulants. Further clinical evaluation (e.g., rheumatology referral) may be appropriate for certain patients.
Does Adhansia XR contain FD&C?
Adhansia XR 45 mg capsules contain FD&C Yellow No. 5 (tartrazine) which may cause allergic-type reactions (including bronchial asthma) in certain susceptible persons. Although the overall incidence of FD&C Yellow No. 5 (tartrazine) sensitivity in the general population is low, it is frequently seen in patients who also have aspirin hypersensitivity.
Can Adhansia XR be used as a stimulant?
CNS stimulants, including Adhansia XR, other methylphenidate-containing products, and amphetamines, have a high potential for abuse and dependence. Assess the risk of abuse prior to prescribing, and monitor for signs of abuse and dependence while on therapy.